| Aktie | Ticker | Breite | GCS | 2026/Q3 | 2026/Q2 | 2026/Q1 | 2025/Q4 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| Gesamt | 21.044.442.318 $ | +1.316.906.911 $ | -10,0 % | 79 | 19.955.238.553 $ | +2.796.792.319 $ | +32,9 % | 83 | 17.415.689.929 $ | +504.825.014 $ | +15,5 % | 83 | 17.078.624.105 $ | +3.471.479.911 $ | +101,7 % | 85 | |||
| INCYTE CORP | INCY | → 0 | Stark | 3.733.047.820 $ | +245.830.091 $ | +7,0 % | 1 | 3.487.217.729 $ | +593.553.672 $ | +20,5 % | 1 | 2.893.664.057 $ | -142.919.934 $ | -4,7 % | 1 | 3.036.583.991 $ | +429.213.932 $ | +16,5 % | 1 |
| BeOne Medicines Ltd. | ONC | → 0 | Neutral | 3.232.104.670 $ | +723.922.122 $ | +28,9 % | 1 | 2.508.182.548 $ | -104.872.221 $ | -4,0 % | 1 | 2.613.054.769 $ | -60.185.523 $ | -2,3 % | 1 | 2.673.240.292 $ | -324.597.065 $ | -10,8 % | 1 |
| Revolution Medicines, Inc. | RVMD | → 0 | Neutral | 2.183.415.893 $ | +40.303.994 $ | +1,9 % | 1 | 2.143.111.899 $ | +1.213.853.431 $ | +130,6 % | 1 | 929.258.468 $ | +176.139.283 $ | +23,4 % | 1 | 753.119.185 $ | +311.554.013 $ | +70,6 % | 1 |
| Kodiak Sciences Inc. | KOD | → 0 | Sehr schwach | 2.072.417.207 $ | +1.296.365.720 $ | +167,0 % | 1 | 776.051.487 $ | +16.732.117 $ | +2,2 % | 1 | 759.319.370 $ | +202.378.929 $ | +36,3 % | 1 | 556.940.441 $ | +273.567.720 $ | +96,5 % | 1 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | → 0 | Schwach | 1.080.052.299 $ | -70.701.891 $ | -6,1 % | 1 | 1.150.754.190 $ | +29.637.968 $ | +2,6 % | 1 | 1.121.116.222 $ | -126.081.938 $ | -10,1 % | 1 | 1.247.198.160 $ | +264.885.579 $ | +27,0 % | 1 |
| INSMED Inc | INSM | → 0 | Schwach | 1.003.988.110 $ | +66.146.755 $ | +7,1 % | 1 | 937.841.355 $ | -275.658.716 $ | -22,7 % | 1 | 1.213.500.071 $ | +66.098.557 $ | +5,8 % | 1 | 1.147.401.514 $ | +182.032.783 $ | +18,9 % | 1 |
| ACADIA PHARMACEUTICALS INC | ACAD | → 0 | Neutral | 864.695.016 $ | -221.001.455 $ | -20,4 % | 1 | 1.085.696.471 $ | +130.816.152 $ | +13,7 % | 1 | 954.880.319 $ | -190.890.271 $ | -16,7 % | 1 | 1.145.770.590 $ | +230.355.225 $ | +25,2 % | 1 |
| Kymera Therapeutics, Inc. | KYMR | → 0 | Schwach | 967.793.083 $ | -24.932.857 $ | -2,5 % | 1 | 992.725.940 $ | +271.664.254 $ | +37,7 % | 1 | 721.061.686 $ | +47.441.686 $ | +7,0 % | 1 | 673.620.000 $ | +297.149.119 $ | +78,9 % | 1 |
| Celcuity Inc. | CELC | → 0 | Neutral | 438.409.005 $ | -458.899.841 $ | -51,1 % | 1 | 897.308.846 $ | -81.068.216 $ | -8,3 % | 1 | 978.377.062 $ | +122.275.945 $ | +14,3 % | 1 | 856.101.117 $ | +424.155.866 $ | +98,2 % | 1 |
| Summit Therapeutics Inc. | SMMT | → 0 | Sehr schwach | 554.417.145 $ | +76.720.055 $ | +16,1 % | 1 | 477.697.090 $ | -212.277.464 $ | -30,8 % | 1 | 689.974.554 $ | +53.494.862 $ | +8,4 % | 1 | 636.479.692 $ | -60.236.951 $ | -8,6 % | 1 |
| RHYTHM PHARMACEUTICALS, INC. | RYTM | → 0 | Schwach | 533.630.849 $ | -88.634.898 $ | -14,2 % | 1 | 622.265.747 $ | +134.843.860 $ | +27,7 % | 1 | 487.421.887 $ | -112.481.973 $ | -18,7 % | 1 | 599.903.860 $ | +33.907.122 $ | +6,0 % | 1 |
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Neutral | 510.583.854 $ | -76.369.304 $ | -13,0 % | 1 | 586.953.158 $ | +22.090.294 $ | +3,9 % | 1 | 564.862.864 $ | +232.841.791 $ | +70,1 % | 1 | 332.021.073 $ | +295.478.209 $ | +808,6 % | 1 |
| GRAIL, Inc. | GRAL | → 0 | Neutral | 564.489.394 $ | +289.455.916 $ | +105,2 % | 1 | 275.033.478 $ | +66.834.706 $ | +32,1 % | 1 | 208.198.772 $ | +29.715.121 $ | +16,6 % | 1 | 178.483.651 $ | +82.094.360 $ | +85,2 % | 1 |
| Alkermes plc. | ALKS | → 0 | Sehr stark | 405.697.059 $ | -118.895.670 $ | -22,7 % | 1 | 524.592.729 $ | +170.558.968 $ | +48,2 % | 1 | 354.033.761 $ | +73.890.530 $ | +26,4 % | 1 | 280.143.231 $ | +37.402.701 $ | +15,4 % | 1 |
| AbCellera Biologics Inc. | ABCL | → 0 | Schwach | 481.647.108 $ | +222.501.825 $ | +85,9 % | 1 | 259.145.283 $ | +153.482.259 $ | +145,3 % | 1 | 105.663.024 $ | +11.525.335 $ | +12,2 % | 1 | 94.137.689 $ | -44.316.280 $ | -32,0 % | 1 |
| Kiniksa Pharmaceuticals International, plc | KNSA | → 0 | Stark | 211.492.714 $ | +30.217.294 $ | +16,7 % | 1 | 181.275.420 $ | +45.191.675 $ | +33,2 % | 1 | 136.083.745 $ | +19.501.097 $ | +16,7 % | 1 | 116.582.648 $ | +6.900.751 $ | +6,3 % | 1 |
| Immunovant, Inc. | IMVT | → 0 | Neutral | 93.583.335 $ | -115.835.692 $ | -55,3 % | 1 | 209.419.027 $ | +73.845.263 $ | +54,5 % | 1 | 135.573.764 $ | -3.165.571 $ | -2,3 % | 1 | 138.739.335 $ | +50.758.293 $ | +57,7 % | 1 |
| Edgewise Therapeutics, Inc. | EWTX | → 0 | Neutral | 150.289.791 $ | -111.052 $ | -0,1 % | 1 | 150.400.843 $ | -56.741.267 $ | -27,4 % | 1 | 207.142.110 $ | +43.960.159 $ | +26,9 % | 1 | 163.181.951 $ | +44.679.604 $ | +37,7 % | 1 |
| IDEAYA Biosciences, Inc. | IDYA | → 0 | Schwach | 192.485.353 $ | +5.761.535 $ | +3,1 % | 1 | 186.723.818 $ | +55.225.938 $ | +42,0 % | 1 | 131.497.880 $ | +6.395.065 $ | +5,1 % | 1 | 125.102.815 $ | +35.977.984 $ | +40,4 % | 1 |
| Roivant Sciences Ltd. | ROIV | → 0 | Neutral | 133.859.073 $ | -33.069.576 $ | -19,8 % | 1 | 166.928.649 $ | +32.092.722 $ | +23,8 % | 1 | 134.835.927 $ | +14.292.058 $ | +11,9 % | 1 | 120.543.869 $ | +63.537.464 $ | +111,5 % | 1 |
| ARROWHEAD PHARMACEUTICALS, INC. | ARWR | → 0 | Neutral | 111.857.519 $ | -50.574.223 $ | -31,1 % | 1 | 162.431.742 $ | +37.484.248 $ | +30,0 % | 1 | 124.947.494 $ | -19.493.578 $ | -13,5 % | 1 | 144.441.072 $ | +86.816.491 $ | +150,7 % | 1 |
| IONIS PHARMACEUTICALS INC | IONS | → 0 | Schwach | 45.715.528 $ | -116.648.746 $ | -71,8 % | 1 | 162.364.274 $ | +8.600.454 $ | +5,6 % | 1 | 153.763.820 $ | +12.011.278 $ | +8,5 % | 1 | 141.752.542 $ | +104.672.617 $ | +282,3 % | 1 |
| Replimune Group, Inc. | REPL | → 0 | Neutral | 146.240.249 $ | +23.968.379 $ | +19,6 % | 1 | 122.271.870 $ | +37.775.050 $ | +44,7 % | 1 | 84.496.820 $ | -22.863.846 $ | -21,3 % | 1 | 107.360.666 $ | +61.080.708 $ | +132,0 % | 1 |
| Immatics N.V. | IMTX | → 0 | Neutral | 37.373.668 $ | -58.948.095 $ | -61,2 % | 1 | 96.321.763 $ | -11.098.496 $ | -10,3 % | 1 | 107.420.259 $ | -19.567.728 $ | -15,4 % | 1 | 126.987.987 $ | +23.946.306 $ | +23,2 % | 1 |
| Abivax S.A. | ABVX | → 0 | Neutral | 97.519.885 $ | -20.585.585 $ | -17,4 % | 1 | 118.105.470 $ | +43.750.390 $ | +58,8 % | 1 | ||||||||
| Nurix Therapeutics, Inc. | NRIX | → 0 | Sehr schwach | 110.454.363 $ | -2.562.206 $ | -2,3 % | 1 | 113.016.569 $ | +40.808.951 $ | +56,5 % | 1 | 72.207.618 $ | -16.165.189 $ | -18,3 % | 1 | 88.372.807 $ | +52.501.972 $ | +146,4 % | 1 |
| Stoke Therapeutics, Inc. | STOK | → 0 | Neutral | 34.163.974 $ | -75.012.752 $ | -68,7 % | 1 | 109.176.726 $ | +533.872 $ | +0,5 % | 1 | 108.642.854 $ | +2.736.091 $ | +2,6 % | 1 | 105.906.763 $ | -2.988.430 $ | -2,7 % | 1 |
| Monte Rosa Therapeutics, Inc. | GLUE | → 0 | Schwach | 51.844.630 $ | -53.322.181 $ | -50,7 % | 1 | 105.166.811 $ | +33.679.454 $ | +47,1 % | 1 | 71.487.357 $ | +3.346.217 $ | +4,9 % | 1 | 68.141.140 $ | +31.712.876 $ | +87,1 % | 1 |
| Structure Therapeutics Inc. | GPCR | → 0 | Neutral | 44.795.182 $ | -32.088.649 $ | -41,7 % | 1 | 76.883.831 $ | +7.835.933 $ | +11,3 % | 1 | 69.047.898 $ | -30.584.494 $ | -30,7 % | 1 | 99.632.392 $ | +56.061.340 $ | +128,7 % | 1 |
| Denali Therapeutics Inc. | DNLI | → 0 | Neutral | 77.188.725 $ | -18.858.397 $ | -19,6 % | 1 | 96.047.122 $ | +24.398.578 $ | +34,1 % | 1 | 71.648.544 $ | +10.038.260 $ | +16,3 % | 1 | 61.610.284 $ | +7.426.073 $ | +13,7 % | 1 |
| Crinetics Pharmaceuticals, Inc. | CRNX | → 0 | 87.991.820 $ | +2.586.611 $ | +3,0 % | 1 | 85.405.209 $ | +8.650.357 $ | +11,3 % | 1 | 76.754.852 $ | +65.092.852 $ | +558,2 % | 1 | |||||
| Celldex Therapeutics, Inc. | CLDX | → 0 | Neutral | 83.131.131 $ | +39.126.176 $ | +88,9 % | 1 | 44.004.955 $ | +22.899.419 $ | +108,5 % | 1 | 21.105.536 $ | +3.034.087 $ | +16,8 % | 1 | 18.071.449 $ | +858.327 $ | +5,0 % | 1 |
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Schwach | 75.033.040 $ | -8.035.907 $ | -9,7 % | 1 | 83.068.947 $ | +11.555.344 $ | +16,2 % | 1 | 71.513.603 $ | +38.967.635 $ | +119,7 % | 1 | 32.545.968 $ | +1.468.951 $ | +4,7 % | 1 |
| Immunocore Holdings plc | IMCR | → 0 | Neutral | 22.142.070 $ | -58.477.320 $ | -72,5 % | 1 | 80.619.390 $ | -3.762.702 $ | -4,5 % | 1 | ||||||||
| BICYCLE THERAPEUTICS PLC | BCYC | → 0 | Schwach | 40.058.114 $ | -6.095.800 $ | -13,2 % | 1 | 46.153.914 $ | -4.354.142 $ | -8,6 % | 1 | 50.508.056 $ | -26.560.272 $ | -34,5 % | 1 | 77.068.328 $ | -7.184.335 $ | -8,5 % | 1 |
| Rapport Therapeutics, Inc. | RAPP | → 0 | Neutral | 51.982.224 $ | -12.485.016 $ | -19,4 % | 1 | 64.467.240 $ | +16.058.794 $ | +33,2 % | 1 | 48.408.446 $ | +1.469.735 $ | +3,1 % | 1 | 46.938.711 $ | +990.138 $ | +2,2 % | 1 |
| Entrada Therapeutics, Inc. | TRDA | → 0 | Schwach | 32.211.836 $ | -5.123.457 $ | -13,7 % | 1 | 37.335.293 $ | -26.682.560 $ | -41,7 % | 1 | 64.017.853 $ | +11.870.189 $ | +22,8 % | 1 | 52.147.664 $ | +23.925.914 $ | +84,8 % | 1 |
| Ultragenyx Pharmaceutical Inc. | RARE | → 0 | Neutral | 63.771.916 $ | -19.630.659 $ | -23,5 % | 1 | ||||||||||||
| Viridian Therapeutics, Inc.\DE | VRDN | → 0 | Neutral | 43.776.169 $ | +5.210.147 $ | +13,5 % | 1 | 38.566.022 $ | -22.792.597 $ | -37,1 % | 1 | 61.358.619 $ | +23.714.338 $ | +63,0 % | 1 | ||||
| ALUMIS INC. | ALMS | → 0 | Neutral | 56.631.750 $ | +12.296.375 $ | +27,7 % | 1 | 44.335.375 $ | +29.085.375 $ | +190,7 % | 1 | 15.250.000 $ | +9.015.625 $ | +144,6 % | 1 | ||||
| Prelude Therapeutics Inc | PRLD | → 0 | Stark | 39.584.152 $ | -14.375.830 $ | -26,6 % | 1 | 53.959.982 $ | +19.336.504 $ | +55,8 % | 1 | 34.623.478 $ | +5.264.388 $ | +17,9 % | 1 | 29.359.090 $ | +14.780.783 $ | +101,4 % | 1 |
| Relay Therapeutics, Inc. | RLAY | → 0 | Schwach | 51.023.433 $ | -1.865.677 $ | -3,5 % | 1 | 52.889.110 $ | +41.345.946 $ | +358,2 % | 1 | 11.543.164 $ | +1.728.574 $ | +17,6 % | 1 | 9.814.590 $ | +3.758.779 $ | +62,1 % | 1 |
| Mirum Pharmaceuticals, Inc. | MIRM | → 0 | Neutral | 38.121.943 $ | -14.088.350 $ | -27,0 % | 1 | 52.210.293 $ | +11.011.122 $ | +26,7 % | 1 | 41.199.171 $ | +41.199.171 $ | 1 | |||||
| Spyre Therapeutics, Inc. | SYRE | → 0 | Neutral | 50.440.000 $ | +17.680.000 $ | +54,0 % | 1 | 32.760.000 $ | +16.000.000 $ | +95,5 % | 1 | ||||||||
| Enliven Therapeutics, Inc. | ELVN | → 0 | Neutral | 41.493.955 $ | -4.444.488 $ | -9,7 % | 1 | 45.938.443 $ | +10.454.956 $ | +29,5 % | 1 | 35.483.487 $ | +31.303.835 $ | +749,0 % | 1 | 4.179.652 $ | +1.829.020 $ | +77,8 % | 1 |
| Design Therapeutics, Inc. | DSGN | → 0 | Neutral | 37.560.970 $ | -1.195.912 $ | -3,1 % | 1 | 38.756.882 $ | +11.242.076 $ | +40,9 % | 1 | 27.514.806 $ | +6.568.337 $ | +31,4 % | 1 | 20.946.469 $ | +8.048.468 $ | +62,4 % | 1 |
| Terns Pharmaceuticals, Inc. | TERN | → 0 | 38.380.000 $ | +38.380.000 $ | 1 | ||||||||||||||
| BioNTech SE | BNTX | → 0 | Neutral | 11.770.737 $ | +628.651 $ | +5,6 % | 1 | 11.142.086 $ | +499.328 $ | +4,7 % | 1 | 10.642.758 $ | -24.478.712 $ | -69,7 % | 1 | 35.121.470 $ | -1.261.716 $ | -3,5 % | 1 |
| Faeth Therapeutics, Inc. | FTH | → 0 | Schwach | 23.893.860 $ | -8.266.415 $ | -25,7 % | 1 | 32.160.275 $ | +32.160.275 $ | 1 | |||||||||
| Aktis Oncology, Inc. | AKTS | → 0 | Neutral | 19.398.954 $ | -12.713.439 $ | -39,6 % | 1 | 32.112.393 $ | +14.287.674 $ | +80,2 % | 1 | 17.824.719 $ | +17.824.719 $ | 1 | |||||
| Neurogene Inc. | NGNE | → 0 | Neutral | 27.588.844 $ | -3.599.838 $ | -11,5 % | 1 | 31.188.682 $ | +11.196.191 $ | +56,0 % | 1 | 19.992.491 $ | -436.344 $ | -2,1 % | 1 | 20.428.835 $ | +3.242.830 $ | +18,9 % | 1 |
| DBV Technologies S.A. | DBVT | → 0 | Sehr schwach | 17.186.358 $ | -6.781.012 $ | -28,3 % | 1 | 23.967.370 $ | -6.561.798 $ | -21,5 % | 1 | 30.529.168 $ | +2.513.651 $ | +9,0 % | 1 | 28.015.517 $ | +13.401.267 $ | +91,7 % | 1 |
| Xencor Inc | XNCR | → 0 | Neutral | 27.497.545 $ | +9.753.638 $ | +55,0 % | 1 | 17.743.907 $ | +4.452.509 $ | +33,5 % | 1 | 13.291.398 $ | -3.581.845 $ | -21,2 % | 1 | 16.873.243 $ | +3.945.540 $ | +30,5 % | 1 |
| Jade Biosciences, Inc. | JBIO | → 0 | Schwach | 17.287.485 $ | -10.052.581 $ | -36,8 % | 1 | 27.340.066 $ | +4.282.091 $ | +18,6 % | 1 | 23.057.975 $ | -2.264.769 $ | -8,9 % | 1 | 25.322.744 $ | +25.322.744 $ | 1 | |
| Taysha Gene Therapies, Inc. | TSHA | → 0 | Neutral | 19.503.162 $ | -7.769.226 $ | -28,5 % | 1 | 27.272.388 $ | +9.371.129 $ | +52,3 % | 1 | 17.901.259 $ | -4.124.899 $ | -18,7 % | 1 | 22.026.158 $ | +8.930.606 $ | +68,2 % | 1 |
| Disc Medicine, Inc. | IRON | → 0 | Neutral | 22.888.547 $ | -2.685.366 $ | -10,5 % | 1 | 25.573.913 $ | +3.216.844 $ | +14,4 % | 1 | 22.357.069 $ | -4.408.072 $ | -16,5 % | 1 | 26.765.141 $ | +4.492.877 $ | +20,2 % | 1 |
| Centessa Pharmaceuticals plc | CNTA | → 0 | 26.642.230 $ | +9.866.747 $ | +58,8 % | 1 | 16.775.483 $ | +16.775.483 $ | 1 | ||||||||||
| Arcus Biosciences, Inc. | RCUS | → 0 | Neutral | 21.821.597 $ | -4.224.080 $ | -16,2 % | 1 | 26.045.677 $ | +17.068.263 $ | +190,1 % | 1 | 8.977.414 $ | +2.543.314 $ | +39,5 % | 1 | 6.434.100 $ | +6.434.100 $ | 1 | |
| Absci Corp | ABSI | → 0 | Neutral | 22.991.828 $ | -1.750.539 $ | -7,1 % | 1 | 24.742.367 $ | +18.337.958 $ | +286,3 % | 1 | 6.404.409 $ | -1.046.053 $ | -14,0 % | 1 | 7.450.462 $ | +7.450.462 $ | 1 | |
| Generate Biomedicines, Inc. | GENB | → 0 | Neutral | 21.382.502 $ | -2.633.664 $ | -11,0 % | 1 | 24.016.166 $ | +6.221.141 $ | +35,0 % | 1 | 17.795.025 $ | +17.795.025 $ | 1 | |||||
| CytomX Therapeutics, Inc. | CTMX | → 0 | Neutral | 13.534.247 $ | -5.125.101 $ | -27,5 % | 1 | 18.659.348 $ | -4.727.034 $ | -20,2 % | 1 | 23.386.382 $ | +5.277.863 $ | +29,1 % | 1 | 18.108.519 $ | +4.548.384 $ | +33,5 % | 1 |
| Xenon Pharmaceuticals Inc. | XENE | → 0 | Schwach | 13.768.036 $ | -8.577.719 $ | -38,4 % | 1 | 22.345.755 $ | +818.160 $ | +3,8 % | 1 | 21.527.595 $ | +4.934.872 $ | +29,7 % | 1 | 16.592.723 $ | +1.728.872 $ | +11,6 % | 1 |
| BIOCRYST PHARMACEUTICALS INC | BCRX | → 0 | Stark | 22.017.271 $ | +22.017.271 $ | 1 | |||||||||||||
| Ventyx Biosciences, Inc. | VTYX | → 0 | 21.213.998 $ | +18.032.064 $ | +566,7 % | 1 | |||||||||||||
| ARGENX SE | ARGX | → 0 | Neutral | 18.383.314 $ | -2.786.761 $ | -13,2 % | 1 | 21.170.075 $ | -6.680.191 $ | -24,0 % | 1 | ||||||||
| Tectonic Therapeutic, Inc. | TECX | → 0 | Neutral | 14.155.383 $ | -6.737.330 $ | -32,2 % | 1 | 20.892.713 $ | +2.105.986 $ | +11,2 % | 1 | 18.786.727 $ | -58.197 $ | -0,3 % | 1 | 18.844.924 $ | +17.275.924 $ | +1.101,1 % | 1 |
| CERUS CORP | CERS | → 0 | Stark | 5.552.909 $ | -13.121.750 $ | -70,3 % | 1 | 18.674.659 $ | +459.471 $ | +2,5 % | 1 | 18.215.188 $ | -2.402.003 $ | -11,7 % | 1 | 20.617.191 $ | +4.703.922 $ | +29,6 % | 1 |
| Evommune, Inc. | EVMN | → 0 | Neutral | 10.199.398 $ | -1.062.415 $ | -9,4 % | 1 | 11.261.813 $ | -8.219.683 $ | -42,2 % | 1 | 19.481.496 $ | +19.481.496 $ | 1 | |||||
| Contineum Therapeutics, Inc. | CTNM | → 0 | Neutral | 18.556.144 $ | +2.315.966 $ | +14,3 % | 1 | 16.240.178 $ | +15.327.555 $ | +1.679,5 % | 1 | ||||||||
| Dyne Therapeutics, Inc. | DYN | → 0 | Neutral | 13.104.663 $ | -4.962.039 $ | -27,5 % | 1 | 18.066.702 $ | +3.318.872 $ | +22,5 % | 1 | 14.747.830 $ | -1.163.232 $ | -7,3 % | 1 | 15.911.062 $ | +15.911.062 $ | 1 | |
| CYTOKINETICS INC | CYTK | → 0 | Neutral | 13.924.608 $ | -4.073.228 $ | -22,6 % | 1 | 17.997.836 $ | +17.997.836 $ | 1 | |||||||||
| Sionna Therapeutics, Inc. | SION | → 0 | Neutral | 17.596.000 $ | +1.560.000 $ | +9,7 % | 1 | 16.036.000 $ | -420.000 $ | -2,6 % | 1 | 16.456.000 $ | +4.692.000 $ | +39,9 % | 1 | ||||
| First Tracks Biotherapeutics, Inc. | TRAX | → 0 | Neutral | 16.760.710 $ | +16.760.710 $ | 1 | |||||||||||||
| SERA PROGNOSTICS, INC. | SERA | → 0 | 11.491.175 $ | +1.484.506 $ | +14,8 % | 1 | 10.006.669 $ | -1.154.616 $ | -10,3 % | 1 | 11.161.285 $ | -5.058.317 $ | -31,2 % | 1 | 16.219.602 $ | -604.798 $ | -3,6 % | 1 | |
| Parabilis Medicines, Inc. | PBLS | → 0 | Neutral | 16.145.000 $ | +2.460.000 $ | +18,0 % | 1 | 13.685.000 $ | +13.685.000 $ | 1 | |||||||||
| Intellia Therapeutics, Inc. | NTLA | → 0 | Schwach | 9.998.379 $ | -5.741.146 $ | -36,5 % | 1 | 15.739.525 $ | +15.739.525 $ | 1 | |||||||||
| Nuvalent, Inc. | NUVL | → 0 | 14.478.623 $ | +2.030.951 $ | +16,3 % | 1 | |||||||||||||
| MapLight Therapeutics, Inc. | MPLT | → 0 | Neutral | 11.889.315 $ | -1.181.712 $ | -9,0 % | 1 | 13.071.027 $ | +5.656.574 $ | +76,3 % | 1 | 7.414.453 $ | +1.008.410 $ | +15,7 % | 1 | 6.406.043 $ | +6.406.043 $ | 1 | |
| COMPASS Pathways plc | CMPS | → 0 | Schwach | 12.966.302 $ | +12.966.302 $ | 1 | |||||||||||||
| Scribe Therapeutics, Inc. | SCTX | → 0 | Schwach | 12.675.358 $ | +12.675.358 $ | 1 | |||||||||||||
| Freenome, Inc. | FRNM | → 0 | Schwach | 12.519.801 $ | +12.519.801 $ | 1 | |||||||||||||
| Avalyn Pharma Inc. | AVLN | → 0 | Stark | 9.971.500 $ | -1.550.500 $ | -13,5 % | 1 | 11.522.000 $ | +11.522.000 $ | 1 | |||||||||
| Pharvaris N.V. | PHVS | → 0 | Neutral | 10.593.750 $ | +187.500 $ | +1,8 % | 1 | 10.406.250 $ | +1.050.000 $ | +11,2 % | 1 | ||||||||
| Tango Therapeutics, Inc. | TNGX | → 0 | Schwach | 8.316.658 $ | -2.103.332 $ | -20,2 % | 1 | 10.419.990 $ | +10.419.990 $ | 1 | |||||||||
| Avalo Therapeutics, Inc. | AVTX | → 0 | Neutral | 8.431.500 $ | -1.732.500 $ | -17,0 % | 1 | 10.164.000 $ | +10.164.000 $ | 1 | |||||||||
| Verastem, Inc. | VSTM | → 0 | Sehr schwach | 9.547.471 $ | +6.448.259 $ | +208,1 % | 1 | 3.099.212 $ | +3.099.212 $ | 1 | |||||||||
| LB PHARMACEUTICALS INC | LBRX | → 0 | Neutral | 7.676.000 $ | +1.185.000 $ | +18,3 % | 1 | 6.491.000 $ | +1.559.000 $ | +31,6 % | 1 | 4.932.000 $ | +480.000 $ | +10,8 % | 1 | 4.452.000 $ | +1.294.000 $ | +41,0 % | 1 |
| Sagimet Biosciences Inc. | SGMT | → 0 | Neutral | 7.366.659 $ | +2.387.255 $ | +47,9 % | 1 | 4.979.404 $ | -662.332 $ | -11,7 % | 1 | 5.641.736 $ | -895.817 $ | -13,7 % | 1 | ||||
| Eikon Therapeutics, Inc. | EIKN | → 0 | Neutral | 4.466.662 $ | -2.783.331 $ | -38,4 % | 1 | 7.249.993 $ | +1.372.221 $ | +23,3 % | 1 | 5.877.772 $ | +5.877.772 $ | 1 | |||||
| Wave Life Sciences, Inc. | WVE | → 0 | Neutral | 4.779.527 $ | -1.184.599 $ | -19,9 % | 1 | 5.964.126 $ | +115.055 $ | +2,0 % | 1 | 5.849.071 $ | +3.330.530 $ | +132,2 % | 1 | ||||
| vTv Therapeutics Inc. | VTVT | → 0 | Neutral | 4.574.004 $ | -1.010.018 $ | -18,1 % | 1 | 5.584.022 $ | -298.111 $ | -5,1 % | 1 | 5.882.133 $ | -48.944 $ | -0,8 % | 1 | 5.931.077 $ | +2.467.945 $ | +71,3 % | 1 |
| Protara Therapeutics, Inc. | TARA | → 0 | Schwach | 5.623.575 $ | +1.912.010 $ | +51,5 % | 1 | 3.711.565 $ | -1.350.544 $ | -26,7 % | 1 | 5.062.109 $ | -116.594 $ | -2,3 % | 1 | 5.178.703 $ | +2.843.484 $ | +121,8 % | 1 |
| Q32 Bio Inc. | QTTB | → 0 | Neutral | 4.531.505 $ | +4.531.505 $ | 1 | |||||||||||||
| 4D Molecular Therapeutics, Inc. | FDMT | → 0 | Schwach | 3.568.028 $ | +3.568.028 $ | 1 | |||||||||||||
| Vir Biotechnology, Inc. | VIR | → 0 | Sehr schwach | 3.271.510 $ | +173.612 $ | +5,6 % | 1 | ||||||||||||
| TScan Therapeutics, Inc. | TCRX | → 0 | 875.817 $ | -1.853.558 $ | -67,9 % | 1 | 2.729.375 $ | -83.265 $ | -3,0 % | 1 | 2.812.640 $ | +27.848 $ | +1,0 % | 1 | 2.784.792 $ | -2.283.529 $ | -45,1 % | 1 | |
| Sana Biotechnology, Inc. | SANA | → 0 | Neutral | 905.058 $ | -178.528 $ | -16,5 % | 1 | 1.083.586 $ | +189.395 $ | +21,2 % | 1 | 894.191 $ | -369.475 $ | -29,2 % | 1 | 1.263.666 $ | -5.946.203 $ | -82,5 % | 1 |
| Immunome Inc. | IMNM | → 0 | Schwach | 1.189.632 $ | +17.698 $ | +1,5 % | 1 | 1.171.934 $ | +1.171.934 $ | 1 | |||||||||
| Skye Bioscience, Inc. | SKYE | → 0 | 317.017 $ | -775.099 $ | -71,0 % | 1 | 1.092.116 $ | +123.972 $ | +12,8 % | 1 | 968.144 $ | -119.399 $ | -11,0 % | 1 | 1.087.543 $ | -4.613.464 $ | -80,9 % | 1 | |
| KALA BIO, Inc. | KALA | → 0 | 1.002.874 $ | -504.318 $ | -33,5 % | 1 | |||||||||||||
| Aligos Therapeutics, Inc. | ALGS | → 0 | Schwach | 467.600 $ | -11.627 $ | -2,4 % | 1 | 479.227 $ | -137.872 $ | -22,3 % | 1 | 617.099 $ | -156.974 $ | -20,3 % | 1 | 774.073 $ | -39.866 $ | -4,9 % | 1 |
| Tyra Biosciences, Inc. | TYRA | → 0 | Schwach | 231.975 $ | -106.813 $ | -31,5 % | 1 | 338.788 $ | -67.460 $ | -16,6 % | 1 | 406.248 $ | +127.390 $ | +45,7 % | 1 | 278.858 $ | +130.466 $ | +87,9 % | 1 |
| Acrivon Therapeutics, Inc. | ACRV | → 0 | Neutral | 54.970 $ | +13.686 $ | +33,2 % | 1 | ||||||||||||
| Surrozen, Inc. | → 0 | 13.750 $ | +417 $ | +3,1 % | 1 | 13.333 $ | -3.334 $ | -20,0 % | 1 | 16.667 $ | +1.834 $ | +12,4 % | 1 | ||||||
| Gesamt | 21.044.442.318 $ | +1.316.906.911 $ | -10,0 % | 79 | 19.955.238.553 $ | +2.796.792.319 $ | +32,9 % | 83 | 17.415.689.929 $ | +504.825.014 $ | +15,5 % | 83 | 17.078.624.105 $ | +3.471.479.911 $ | +101,7 % | 85 | |||
Keine Anlageberatung, keine individuelle Empfehlung.
Der Glück Conviction Score und die daraus abgeleiteten Einstufungen und Hinweise sind das Ergebnis eines
überwiegend regelbasierten Scoring-Modells aus öffentlich verfügbaren Daten (SEC-Filings,
Fundamentaldaten, Kursdaten). Sie richten sich an ein breites Publikum und
berücksichtigen keine persönlichen Verhältnisse, Anlageziele oder Risikobereitschaften.
Ersteller: Verantwortlich für Erstellung und Verbreitung ist der Betreiber dieser Website (siehe Impressum). Die Einstufung wird arbeitstäglich automatisiert neu berechnet — Stand: 20.11.2026.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in besprochenen Werten halten. Methodik: Methodik und Datenquellen.
Ersteller: Verantwortlich für Erstellung und Verbreitung ist der Betreiber dieser Website (siehe Impressum). Die Einstufung wird arbeitstäglich automatisiert neu berechnet — Stand: 20.11.2026.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in besprochenen Werten halten. Methodik: Methodik und Datenquellen.
Keine Anlageberatung, keine individuelle Empfehlung.
Der Glück Conviction Score ist das Ergebnis eines überwiegend regelbasierten Scoring-Modells aus öffentlich
verfügbaren Daten. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.